News
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...
3d
MedPage Today on MSNMifepristone Helped Control Diabetes in Those With HypercortisolismCHICAGO -- Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and ...
4d
MedPage Today on MSNOnce-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 DiabetesCHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...
The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...
11h
Everyday Health on MSNDitching Diet Soda Tied to Weight Loss and Higher Chance of Diabetes RemissionWomen with diabetes who were overweight or had obesity lost more weight and had greater odds of diabetes remission when ...
For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...
Results presented at the 85th Scientific Sessions of the American Diabetes Association in Chicago highlight the potential for ...
Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) American Diabetes Association (ADA) 85th Scientific Sessions Conference June 20, 2025 8:15 PM ET James Markmann - Corporate Participant Michael ...
VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...
Special Call (Lilly Investor Event at American Diabetes Association's (ADA) 85th Scientific Sessions) Conference June ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results